Ultragenyx Pharmaceutical (RARE) Treasury Shares (2023 - 2026)
Ultragenyx Pharmaceutical's Treasury Shares came in at $10 million for Q2 2026, up 25.1% from $7.99 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Treasury Shares (2023 - 2026) Analysis & Trends
At the end of FY2025, Ultragenyx Pharmaceutical's Treasury Shares was $8 million, up 100.0% from FY2024.
- Going back by year, Treasury Shares was $4 million in FY2024 (+825.9%) and $432,000 in FY2023.
- Year-over-year, Treasury Shares has increased for ten consecutive quarters, with growth averaging 275.4% over the last eight quarters.
- Over the past five years, the year-over-year growth in Treasury Shares ranged from 25.1% (Q2 2026) to 836.0% (Q1 2024).
- Business Quant data shows RARE's Treasury Shares at $10 million (Q1 2026), $8 million (Q4 2025) and $7.99 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 711.62 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 77.11 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.11 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -49.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Ultragenyx Pharmaceutical | 1.48 Bn | -321.29 Mn | 180.00 Mn | 300,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 300,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 173,034.00 |
| Jun 30, 2025 | 173,034.00 |
| Mar 31, 2025 | 162,344.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 68,923.00 |
| Jun 30, 2024 | 65,063.00 |
| Mar 31, 2024 | 63,575.00 |
| Dec 31, 2023 | 9,559.00 |
| Sep 30, 2023 | 8,444.00 |
| Jun 30, 2023 | 8,444.00 |
| Mar 31, 2023 | 7,812.00 |
API Access
Ultragenyx Pharmaceutical Treasury Shares API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=treasury-shares&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "treasury-shares", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=treasury-shares&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();